Karpus Investment Management’s abrdn Life Sciences Investors HQL Stock Holding History

Karpus Investment Management’s Portfolio HQL Stock Details HQL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-300,284	Closed	-$4.66M	–	221
2025 Q3	$4.66M	Sell	300,284 -130,436	-30%	-$1.79M	0.15%	112
2025 Q2	$5.52M	Sell	430,720 -36,971	-8%	-$456K	0.18%	116
2025 Q1	$5.93M	Sell	467,691 -21,881	-4%	-$296K	0.19%	117
2024 Q4	$6.42M	Buy	489,572 +20,974	+4%	+$303K	0.19%	106
2024 Q3	$7.07M	Buy	468,598 +64,214	+16%	+$972K	0.2%	106
2024 Q2	$5.73M	Buy	404,384 +58,866	+17%	+$796K	0.16%	102
2024 Q1	$4.71M	Buy	+345,518	New	+$4.78M	0.14%	115
2020 Q3	–	Sell	-65,215	Closed	-$1.17M	–	214
2020 Q2	$1.17M	Sell	65,215 -72,340	-53%	-$1.24M	0.04%	149
2020 Q1	$2.06M	Buy	137,555 +1,990	+1%	+$32.6K	0.08%	132
2019 Q4	$2.36M	Buy	+135,565	New	+$2.22M	0.08%	128
2014 Q3	–	Sell	-17,500	Closed	-$363K	–	184
2014 Q2	$363K	Buy	+17,500	New	+$367K	0.02%	154

Other funds holding HQL

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

NIM

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

FHA

Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Karpus Investment Management's HQL Position: Q4 2025 in Review

Karpus Investment Management sold out of abrdn Life Sciences Investors (HQL) in Q4 2025, closing a stake of 300,284 shares — an estimated $4.66M sold.

Karpus Investment Management first reported a position in HQL in Q2 2014 and held it in 11 quarters. The position peaked at $7.07M in Q3 2024. 73 funds tracked by Wall St. Rank hold HQL as of Q4 2025.

Karpus Investment Management reported no remaining abrdn Life Sciences Investors position as of Q4 2025 after selling out during the quarter.
Karpus Investment Management sold 300,284 abrdn Life Sciences Investors shares in Q4 2025, an estimated $4.66M.
Karpus Investment Management first reported a position in abrdn Life Sciences Investors in Q2 2014 and held it in 11 quarters.
Karpus Investment Management's abrdn Life Sciences Investors position peaked at $7.07M in Q3 2024.
73 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q4 2025.

Based on Karpus Investment Management's 13F filing for Q4 2025, filed 13 Feb 2026.